Wakefield, MA (PRWEB) November 13, 2013
TraceLink Inc., the leader in global pharmaceutical track and trace and supply network towers, announced today that it has filed a reexamination petition with the United States Patent and Trademark Office relating to patent 6996538 owned by Unisone Strategic IP, Inc., a financial stakeholder in Frequentz, LLC.
On July 25, 2013, Unisone filed a complaint (case # ‘13CV1743 JAH WVG, U.S. District Court for the Southern District of California) alleging TraceLink is in violation of a patent held by Unisone concerning inventory control. This was the second lawsuit filed in 2013 by Unisone (see Unisone Strategic IP, Inc. v. Life Technologies Corporation et al. case # ‘13CV1278 GPC JMA, U.S. District Court for the Southern District of California) that according to court documents alleged infringement of a 2006 patent Unisone was granted on inventory control systems.
TraceLink filed a 665 page patent reexamination petition of the ‘538 patent on November 4, 2013 with the United States Patent and Trademark Office (see USPTO Application Number 09799879). TraceLink has asked industry participants and software technology providers to submit additional prior art. Interested parties who would like to learn more about the reexamination petition and supporting prior art may visit here or contact TraceLink for more information.
“TraceLink has worked tirelessly to develop unique, innovative software solutions that help the pharmaceutical industry protect patient safety and improve global access to safe medicines,” said Shabbir Dahod, President and CEO of TraceLink. “As shown in the court documents, we are vigorously defending the innovations of the TraceLink Life Science Cloud platform against infringement claims. Furthermore, TraceLink has filed a patent reexamination petition on the underlying Unisone patent.”
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from raw materials to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit http://www.tracelink.com or follow us on LinkedIn.